监测性结肠镜对结直肠癌预防的贡献
基于PLCO试验结肠镜队列(n=15935)随访10年,通过腺瘤停留时间避免(DTA)指标间接估算监测性结肠镜的预防效果。总体结直肠癌发病率估计降低30.4%(95%CI 25%-40%),进展期腺瘤者降低25.0%(95%CI 16%-34%),1-2个非进展期腺瘤者降低34.4%(95%CI 25%-40%)。因方法为间接估算,真实效应不确定。
要点
- 监测性结肠镜在10年随访中估计预防约30%的结直肠癌病例。
- 进展期腺瘤者CRC发病率绝对降低7.1/10000人年。
- 1-2个非进展期腺瘤者绝对降低4.1/10000人年。
核心结论
- 在PLCO结肠镜队列10年随访中,监测性结肠镜估计预防了30%的结直肠癌病例。
- 因估算方法为间接法,真实预防效果尚不确定。
研究设计与样本
- 研究随访PLCO癌症筛查试验中乙状结肠镜阳性后接受结肠镜检查的受试者(结肠镜队列,n=15935)10年内的CRC发病情况。
- 在子集(n=3492)中测量监测期间切除腺瘤的数量和时机,并外推至整个队列以估算总避免的腺瘤停留时间。
- 应用先前确定的DTA值612停留年估算监测预防的CRC病例数,并以CP/(CO+CP)计算CRC比例降低。
主要发现
- 结肠镜队列中2882例有进展期腺瘤(AA),572例有3个及以上非进展期腺瘤(NAA3+),4496例有1-2个非进展期腺瘤(NAA1-2),7985例无腺瘤(NA)。
- 10年内平均后续结肠镜检查次数:AA者1.80次,NAA3+者1.63次,NAA1-2者1.46次。
- 人均避免腺瘤停留时间:AA者4.0年,NAA3+者5.5年,NAA1-2者2.4年。
- CRC病例数:AA者56例,NAA3+者4例,NAA1-2者33例。
- CRC发病率估计比例降低:AA者25.0%(95%CI 16%-34%),NAA1-2者34.4%(95%CI 25%-40%),总体(AA、NAA3+或NAA1-2者)30.4%(95%CI 25%-40%)。
关键数值与推荐
- DTA值612停留年用于估算监测性结肠镜预防的CRC病例数。
- CRC发病率绝对降低:AA者7.1/10000人年,NAA1-2者4.1/10000人年。
临床怎么用
- 监测性结肠镜对结直肠癌预防有可测量的贡献,尤其对进展期腺瘤和1-2个非进展期腺瘤者。
- 临床决策时可参考监测性结肠镜的估计预防效果,但需知晓其基于间接估算方法。
局限性
- 研究方法为间接估算,真实预防效果不确定。
- 腺瘤切除数量与时机仅在子集(n=3492)中测量并外推至全队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The contribution of surveillance colonoscopy, as opposed to that of initial colonoscopy examination, to prevention of colorectal cancer (CRC) is uncertain. We estimated the preventive effect of surveillance colonoscopy by applying the recently developed metric of adenoma dwell time avoided needed to prevent 1 CRC case (DTA). METHODS: We followed subjects in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial who underwent colonoscopies following positive findings from sigmoidoscopies (colonoscopy cohort, n = 15,935) for CRC incidence for 10 years. The number and timing of adenomas removed during surveillance were measured in a subset (n = 3492) of patients and extrapolated to the entire cohort to estimate the total avoided adenoma dwell time. A previously determined DTA value of 612 dwell years was applied to estimate the number of CRC cases prevented by surveillance. Proportional reduction in CRC was computed as CP/(CO+CP), where CO and CP are observed and estimated prevented cases, respectively. RESULTS: In the colonoscopy cohort of the PLCO, 2882 subjects had advanced adenomas (AAs), 572 had 3 or more non-advanced adenomas (NAA3+), 4496 had 1-2 non-advanced adenomas (NAA1-2), and 7985 had no adenoma (NA). The mean number of subsequent colonoscopy examinations over 10 years were 1.80 for subjects with AAs, 1.63 for subjects with NAA3+, and 1.46 for subjects with NAA1-2. Average years of avoided adenoma dwell time per subject were 4.0 for subjects with AAs, 5.5 for subjects with NAA3+, and 2.4 for subjects with NAA1-2. There were 56 cases of CRC in subjects with AAs, 4 cases of CRC in subjects with NAA3+, and 33 cases of CRC in subjects with NAA1-2. Estimated proportional reductions in CRC incidence were 25.0% in subjects with AAs (95% CI, 16%-34%), 34.4% in subjects with NAA1-2 (95% CI, 25%-40%), and 30.4% overall (in subjects with AAs, NAA3+, or NAA1-2; 95% CI, 25%-40%). Absolute CRC incidence reductions were 7.1 per 10,000 PY in subjects with AAs and 4.1 per 10,000 PY in subjects with NAA1-2. CONCLUSIONS: Using the recently developed metric of DTA, we estimated that surveillance colonoscopy in the PLCO colonoscopy cohort during 10 years of follow up prevented 30% of CRC cases. Because the methodology for estimation is indirect, the true effect is uncertain.
引用
- Pinsky PF, Schoen RE. Contribution of Surveillance Colonoscopy to Colorectal Cancer Prevention. Clin Gastroenterol Hepatol. 2020. PMID: 32017987. doi:10.1016/j.cgh.2020.01.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。